- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01264146
Hyperbaric Oxygen Therapy in Calcaneal Intraarticular Fractures: Can it Decrease the Soft-tissue Complication Rate? (HOCIF)
November 26, 2012 updated by: RWTH Aachen University
This study aims to test the hypothesis that postoperative daily hyperbaric oxygen therapy (HBOT) decreases soft-tissue complication rate during the operative handling of intra-articular calcaneal fractures.
Minor motivations: 1.
To evaluate microcirculatory criteria of cutaneous tissue predicting emerging wound healing defects, 2. To identify patients at risk for soft-tissue complication after calcaneal plate osteosynthesis and to determine the optimal time point for operative intervention using these microcirculatory criteria preoperatively, 3. To evaluate the effect of HBOT on postoperative microcirculation, 4. To collect preliminary data to evaluate the economical impact of wound complications, with and without HBOT, 5. To identify a correlation between HBOT with expected limited soft-tissue complication rate and the clinical and radiographic outcome two years after surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Wound complication remains an important problem in calcaneal fractures, with some plate series quoting up to a 27% infection rate.
The original hypothesis stimulating this study is that HBOT after calcaneal plating can decrease such high rates of infection.
Validation of this hypothesis would not only alter guidelines for standard procedure (plate osteosynthesis), but would also help to avoid difficult follow-up operations and improve functional outcome after calcaneal fracture.
To date, this therapeutic approach has not been systematically tested in the existing literature.
As further motivation for this study, the assessment of the existent microcirculation as a potential screening parameter will be analysed.
In order to do so, it is assumed that wound infection partially develops due to disruptions in the microcirculation.
This leads to the hypotheses, that by measuring the microcirculation, patients at high risk for post operative infections could be identified before operation, planning a different less invasive approach or conservative treatment.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Aachen, Germany, 52074
- RWTH Aachen University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Acute displaced intraarticular calcaneal fracture
Exclusion Criteria:
- Extraarticular or open fracture, re-fracture or past surgical procedures in calcaneal region, peripheral vascular disease, insulin dependent diabetes mellitus, macroangiopathy: Study population is representative for all calcaneal fractures
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: calcaneal plating HBOT
Open reduction and internal fixation of calcaneal fracture + HBOT
|
Open reduction and internal fixation of calcaneal fracture + hyperbaric oxygen therapy 20 postoperative days (one time, 90 minutes a day)
Other Names:
|
PLACEBO_COMPARATOR: calcaneal plating
Open reduction and internal fixation of calcaneal fracture + Placebo (Sham)
|
open reduction and internal fixation of calcaneal fracture + Placebo (Sham)
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative rate of wound complication after calcaneal plating
Time Frame: 30 days
|
Rate of postoperative wound edge necrosis and superficial or deep infection determined by wound redness, secretion of pus, detection of a microbial agens, CRP elevation and detection of fluid by sonography.
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of HBOT on postoperative microcirculation of the foot, clinical outcome
Time Frame: 2 years
|
Complications later than day 20 post-surgery, clinical and radiographic outcome (2years follow-up), To evaluate microcirculatory criteria of cutaneous tissue, To identify patients at risk for soft-tissue complication after calcaneal plate osteosynthesis and to determine the optimal time point for operative intervention, To evaluate the effect of HBOT on postoperative microcirculation, To identify a correlation between HBOT with expected limited soft-tissue complication rate and the clinical and radiographic outcome two years after surgery.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2011
Primary Completion (ACTUAL)
November 1, 2012
Study Completion (ACTUAL)
November 1, 2012
Study Registration Dates
First Submitted
December 17, 2010
First Submitted That Met QC Criteria
December 19, 2010
First Posted (ESTIMATE)
December 21, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
November 27, 2012
Last Update Submitted That Met QC Criteria
November 26, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTC-A10-025
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wound Healing
-
University of Witten/HerdeckeKCI Europe Holding B.V.CompletedImpaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous WoundBelgium, Germany
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
First Affiliated Hospital, Sun Yat-Sen UniversityRecruiting
-
3MRecruiting
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Riyadh Elm UniversityUnknown
-
Icahn School of Medicine at Mount SinaiTerminated
-
OcuNexus Therapeutics, Inc.Completed
-
Stratpharma AGUniversity Hospital, GenevaCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedWound HealingUnited States
Clinical Trials on HBOT
-
Assaf Harofeh MCUnknown
-
Assaf-Harofeh Medical CenterUnknownIntracranial Meningioma | Neurologic DeficitsIsrael
-
Assaf-Harofeh Medical CenterCompletedFibromyalgia | Chronic Pain SyndromeIsrael
-
Abington Memorial HospitalPhiladelphia College of Osteopathic MedicineCompletedStroke | Ischemic Stroke | Chronic Stroke | Motor DysfunctionUnited States
-
Assaf-Harofeh Medical CenterWeizmann Institute of Science; Office of Naval Research (ONR)RecruitingPTSD | Peritraumatic AmnesiaIsrael
-
Mrs. Thelma Zoegas FoundationLund University; Region Skåne Sweden; Gorthons Foundation Helsingborg SwedenCompletedDiabetes | Foot Ulcer | HealingSweden
-
Kenneth Peters, MDWilliam Beaumont HospitalsCompletedInterstitial CystitisUnited States
-
Assaf-Harofeh Medical CenterCompletedErectile Dysfunction | Hyperbaric Oxygen TherapyIsrael